2012 YEAR IN REVIEW

January 2012

  • The Journal of the American Medical Association (JAMA) published results by Pennington Biomedical researcher Dr. George Bray, which showed dietary protein affects body weight, lean mass and energy expenditure during overeating; but calories alone account for the increase in the amount of body fat
  • U.S. News and World Report selected the DASH diet as the #1 best diet overall in America for 2012.  Pennington Biomedical was a key contributor to the NIH-funded DASH studies, led by Drs. George Bray and Catherine Champagne

February 2012

  • Pennington Biomedical announced the retirement of long-time Associate Executive Director of Clinical Research, Dr. Donna Ryan, who played a critical role in developing the Center’s clinical research efforts over the past 23 years.  The LSU Board of Supervisors recognized her leadership with the designation of the Donna H. Ryan, M.D. Clinical Conference Room, located in Pennington Biomedical’s new Clinical Research Building
  • Pennington Biomedical announced the appointment of Dr. William T. Cefalu as Associate Executive Director of Clinical Research

March 2012

  • Diabetes Care published findings from Pennington Biomedical’s Diabetes Prevention Program study, led by Dr. George Bray, that showed lifestyle interventions and treatment with metformin provide safe, long-term, cost-effective means of prevention type 2 diabetes and should be incorporated into prevention strategies for reducing the dramatic rise in the incidence of type 2 diabetes in the U.S.  Pennington Biomedical researcher Dr. William Cefalu, and editor of Diabetes Care, provided the editorial which called for an increased focus on translating the growing body of research on prevention into primary care and community treatment strategies
  • The New England Journal of Medicine (NEJM) published results that included Pennington Biomedical researcher Dr. George Bray’s NIH-funded Look AHEAD study, which found that weight loss and increased physical fitness nearly halved the risk of losing mobility in overweight or obese adults with type 2 diabetes
  • Pennington Biomedical was recognized as one of the highest ranked institutions in The Scientist’s annual listing of Best Places to Work for Postdocs. The publication surveyed more than 1,500 postdoctoral fellows globally and ranked Pennington Biomedical number 4 on the 2012 listing among a highly prestigious selection of research institutions

April 2012

  • Pennington Biomedical was awarded a five-year, $2.3 million grant from the National Institutes of Health (NIH) to investigate a program designed to improve the health and well-being of female collegiate athletes.  Dr. Tiffany Stewart will lead the program

May 2012

  • Dr. Eric Ravussin, a Pennington Biomedical researcher whose work is helping to unravel the causes of obesity, was unanimously promoted by the LSU Board of Supervisors to Boyd Professor, the LSU System’s highest academic rank
  • Rudolph L. Leibel, M.D., received an honorary doctorate degree for his internationally recognized diabetes research at LSU Health Sciences Center
  • Pennington Biomedical researcher Dr. Claude Bouchard led a study that found a significant fraction of sedentary adults develop one or more adverse responses when they exercise regularly

June 2012

  • Pennington Biomedical researchers contributed to a studypublished by Obesity Review that provided the most advanced attempt to explain why individuals do not lose more weight from an exercise intervention

July 2012

  • BMJ Open published study findings, co-written by Pennington Biomedical’s Peter Katzmarzyk, that showed restricting the amount of time spent seated every day to less than 3 hours might boost life expectancy of US adults by an extra 2 years
  • Pennington Biomedical’s Dr. Peter Katzmarzyk joined a group of top global physical activity researchers in London for the launch of a special series of studies published in The Lancet. In a study included in the series, Dr. Katzmarzyk and other researchers found strong evidence showing that inactivity increased the risk of many adverse health conditions, including coronary heart disease, type 2 diabetes, breast and colon cancers, as well as a shortened life expectancy

August 2012

  • Pennington Biomedical researcher Dr. Claude Bouchard co-authored a study that was the first to definitively show that weight loss, accomplished in obese patients with bariatric surgery, can prevent the onset of serious diseases such as type 2 diabetes in most people who have a series weight problem

September 2012

  • Louisiana Clinical and Translation Science Center (LA CaTS), led by Pennington Biomedical Research Center, was awarded a $20 million, five-year NIH grant to support biomedical research.  The collaborative effort among eight higher educational academic, research and health care delivery institutions in Louisiana is aimed at providing the infrastructure to facilitate research in chronic disease prevention and improve healthcare in underserved populations
  • Pennington Biomedical researcher Dr. Nikhil Dhurandhar was named vice president of the Obesity Society for 2012-2013, and will serve as president-elect (2013-2014), president (2014-2015), and immediate past president (2015-2016)
  • Pennington Biomedical Research Center and Kinexum announced plans to integrate regulatory and developmental strategy and clinical trials to accelerate translational research for therapies in diabetes, obesity, and chronic metabolic diseases
  • PLOS ONE published findings from a Pennington Biomedical study, led by Dr. Stephanie Broyles, that determined children living in high poverty or high crime neighborhoods have elevated levels of C-reactive protein, a marker for inflammation and, in adults a risk factor for cardiovascular disease

October 2012

  • Pennington Biomedical researcher Dr. Nikhil Dhurandhar was appointed as the John Henry Hernandez Endowed Professor in Health Promotion by the LSU Board of Supervisors
  • Pennington Biomedical hosted the 5th Annual Childhood Obesity & Public Health Conference led by Dr. Peter Katzmarzyk.  More than 400 public health professionals, educators, and business leaders attended
  • As part of Pennington Biomedical’s childhood obesity initiative, led by Dr. Peter Katzmarzyk, Louisiana’s Report Card on Physical Activity & Health for Children & Youth was released

December 2012

  • American Journal of Preventative Medicine published a Pennington Biomedical research study, led by Dr. Peter Katzmarzyk, that found having a bedroom TV and TV viewing time were related to childhood obesity, and specifically high waist circumference

 

Educational & Community Programs

February 2012

  • Pennington Biomedical hosted the 10th Annual Irene W. Pennington Wellness Day for Women, a community event for women with free health screenings and educational seminars
  • Pennington Biomedical’s Botanical Research Center hosted the 6th Annual Botanical Community Workshop, led by Dr. William Cefalu, which focused on botanicals and metabolic syndrome

August 2012

  • Pennington Biomedical hosted the 1st Annual Parkinson’s Conference.  More than 300 Parkinson’s patients, caregivers and providers attended
  • Pennington Biomedical was the host site for the 11th Annual Louisiana Men’s Health Conference, which provided men of all ages an opportunity to explore ways to better care for themselves and their health

September 2012

  • Pennington Biomedical hosted the 4th Annual Public Forum on Dementia Research in Baton Rouge, led by Dr. Jeffrey Keller

October 2012

  • Pennington Biomedical Research Center co-hosted the 2nd International Conference on Hyperphagia and the 26th Annual Prader-Willi Syndrome Association (USA).  Top scientists in the field of appetite and obesity research presented the latest information on the various aspects of appetite control.